Influence of anticoagulants on the measurement of S100B protein in blood

Clinical Biochemistry

Volumn 36, Issue 8, 2003, Pages 629-632

  Tort, Adriano B L ^a   Dietrich, Marcelo O ^a   Gonçalves, Carlos A ^a   Souza, Diogo O ^a   Portela, Luis V C ^a  

^a NONE

Author keywords

Anticoagulants; Blood; Immunoluminometric assay; S100B

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; EDETIC ACID; HEPARIN; PROTEIN S100B;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; HUMAN; LABORATORY TEST; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0242551219     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(03)00107-3     Document Type: Article

References (11)

1. Donato R. S100 a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular, and extracellular functional roles. Int J Biochem Cell Biol. 33:2001;637-668.
2. Ingebrigtsen T., Waterloo K., Jacobsen E.A., Langbakk B., Romner B. Traumatic brain damage in minor head injury relation of serum S-100 protein measurements to magnetic resonance imaging and neurobehavioral outcome. Neurosurgery. 45:1999;468-475.
3. Wunderlich M.T., Ebert A.D., Kratz T., Goertler M., Jost S., Herrmann M. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke. 30:1999;1190-1195.
4. Lara D.R., Gama C.S., Belmonte-de-Abreu P., Portela L.V., Gonçalves C.A., Fonseca M., et al. Increased serum S100B protein in schizophrenia a study in medication-free patients. J Psychiatr Res. 35:2001;11-14.
5. Walz R., Portela L.V., Tort A.B., Neto E.C., Fernandes L.N., Gonçalves C.A., et al. Serum S100B levels in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurology. 54:2000;2021-2022.
6. Portela L.V., Tort A.B., Schaf D.V., Ribeiro L., Nora D.B., Walz R., et al. The serum S100B concentration is age dependent. Clin Chem. 48:2002;950-952.
7. Missler U., Wiesmann M., Ehlermann P., Tronnier M., Notzold A., Steinmeier E., et al. Validation and comparison of two solid-phase immunoassays for the quantification of S-100B in human blood. Clin Chem. 46:2000;993-996.
8. Hamberg A.P., Korse C.M., Bonfrer J.M., de Gast G.C. Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma. Melanoma Res. 13:2003;45-49.
9. Beaudeux J.L., Leger P., Dequen L., Gandjbakhch I., Coriat P., Foglietti M.J. Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem. 46:2000;989-990.
10. Gao F., Harris D.N., Sapsed-Byrne S., Sharp S. Neurone-specific enolase and Sangtec 100 assays during cardiac surgery Part I-The effects of heparin, protamine and propofol. Perfusion. 12:1997;163-165.
11. Goncalves C.A., Gottfried C., Kommers T., Rodnight R. Calcium-modulated proteins change their immunoreactivity in the presence of Ca2+ a study of antibody recognition in a dot immunoassay for calmodulin, calcineurin (beta-subunit), and S100B. Anal Biochem. 253:1997;127-130.